Home News Bulk Drug

Bulk Drug

India’s dependence on imports for bulk drugs and APIs

New Delhi, May 09, 2015: As per the Boston Consulting Group Report of 2013 import of Active Pharmaceutical Ingredients (APIs) during the year 2013 was approximately US $ 3.5 billion of which a large share was from China. The...

Alembic Pharma gets USFDA nod for Darifenacin Extended Tablets

Mumbai, December 14, 2017: Pharma Major, Alembic Pharmaceuticals said that it company received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Darifenacin extended release tablets, 7. 5mg and 15mg. Darifenacin extended release...

WOCKHARDT ISSUES A VOLUNTARILY RECALL OF ANTI-HYPERTENSIVE DRUGS FROM US MARKET

New Delhi, June 18, 2014 - Wockhardt Ltd. has issued a voluntary recall of 8,712 bottles of anti-hypertensive drug Metoprolol Succinate extended-release tablets from the US market due to failure of a dissolution test. According to US Food and...

Westernization and Industrialization in Australia to boost Drug Delivery Devices Market: Ken Research

New Delhi, December 27, 2017: Australia encouraged nanotechnology applications in various sectors such as energy, food, water, drug delivery and new ways to regenerate damaged parts of a human body such as blood vessels, brain, nerves, bone and cartilage....

Strides Shasun subsidiary receives USFDA approval for Acetazolamide tablets

Mumbai, November 27, 2017: Pharma Major,Strides Shasun's said that its wholly owned subsidiary Strides Pharma Global has received approval from the United States Food & Drug Administration (USFDA) for Acetazolamide Tablets USP, 125 mg and 250 mg., a generic version of Diamox Tablets. The...

ANTI-ALLERGIC DRUGS RECALLED BY ZYDUS CADILA FROM US MARKET

New Delhi, June 12, 2014 - Zydus Cadila issued a voluntary recall of nearly 10,200 bottles of an anti-allergic drug from the US market. The recall was started by the company’s US unit, Zydus Pharmaceuticals USA Inc. due to...

GSK-Dr Reddy’s to file for joint drug this year

Hyderabad February 19, 2014:- The first drug being jointly developed by GlaxoSmithKline (GSK) and Dr Reddy’s Laboratories will be filed for registration in this year. Speaking to newspersons on the sidelines of the ongoing BioAsia 2014 here on Tuesday,...

Dangers of commonly prescribed painkillers highlighted A recent study done by Newcastle University

New Delhi, December 12, 2017: Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed Over the past 10 years, there has been a...

NPPA fixes retail prices of 14 formulations

New Delhi, January 04, 2018: Drug price regulator has also asked manufacturers to furnish quarterly return regarding production, import and sale of their products. Drug price regulator NPPA has fixed retail prices of 14 formulations, including of those used in treatment of...

Code for pharma marketing practices may be enforced soon

A revised final draft of Uniform Code of Pharmaceuticals Marketing Practices has been sent to the law ministry for vetting New Delhi, December 27, 2017: A revised final draft of a code regulating promotional practices in the pharmaceuticals industry, such as...